DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
rareLife solutions 606 Post Road East #397 Westport, CT 06880 |
||
You are receiving this because you have an account on www.oneAMYLOIDOSISvoice.com | ||
To unsubscribe from these emails, click here |
Trusted Resources: News & Meetings
Latest announcements and gatherings
Doctors Making Progress in Treating Amyloidosis
Amyloidosis is a rare condition that used to almost always be fatal, but doctors are finally making progress in treating it.
“I had so many symptoms, and I really didn’t think they all connected,” Pam Rafferty said.
Rafferty had a thick tongue, leg swelling, frothy urine, carpal tunnel syndrome, and then…
“I started having heart palpitations,” Rafferty said.
She had atrial fibrillation, an abnormal heart rhythm. But her cardiologist noticed something else was abnormal — the rapidly increasing muscle thickness in her heart, a sign of a condition called amyloidosis. It’s rare — only 10 cases for every 1 million people.
“Their hearts become thickened over time, which leads to stiffening of the heart and heart failure,” Allegheny Health Network cardiologist Dr. Travis Wilson said.

Source: pittsburgh.cbslocal.com
Share

Related Content
-
people & placesVan Selby, MDDr. Van Selby is a cardiologist who spec...
-
people & placesBarry Trachtenberg, MDDr. Barry H. Trachtenberg is an Assistan...
-
educationLong-Term Outcome of Patients with AL Amyloidosis Treated With High-Dose Melphalan and Stem Cell TransplantationIn immunoglobulin light chain (AL) amylo...
-
videos & visualsDr. Rosenzweig Discusses the Standard of Care in Amyloidosishttps://www.youtube.com/watch?v=5lewKqzm...
-
people & placesAnuj Mahindra, MDAnuj Mahindra is a hematologist and medi...
-
educationAL Amyloidosis: From Molecular Mechanisms to Targeted TherapiesSystemic amyloidosis is caused by misfol...
-
educationCurrent and Future Circulating Biomarkers for Cardiac AmyloidosisCardiac amyloidosis (CA) comprises a het...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.